HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: HSK7653 10 mg Q2W; Drug: HSK7653 25 mg Q2W; Drug: Placebo Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Diets | Endocrinology | Nutrition | Research | Sports Medicine